Utah Medical Products Files 8-K
Ticker: UTMD · Form: 8-K · Filed: Oct 23, 2025 · CIK: 706698
| Field | Detail |
|---|---|
| Company | Utah Medical Products Inc (UTMD) |
| Form Type | 8-K |
| Filed Date | Oct 23, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, operations, filing
Related Tickers: UTMD
TL;DR
UTMD filed an 8-K on Oct 23, 2025, updating financials and operations.
AI Summary
Utah Medical Products, Inc. filed an 8-K on October 23, 2025, reporting on its results of operations and financial condition. The filing also includes financial statements and exhibits. The company is incorporated in Utah and its principal executive offices are located in Midvale.
Why It Matters
This 8-K filing provides an update on Utah Medical Products' financial performance and operational status, which is crucial for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This is a routine 8-K filing reporting on financial condition and operations, not indicating any immediate significant risks.
Key Players & Entities
- UTAH MEDICAL PRODUCTS, INC. (company) — Registrant
- October 23, 2025 (date) — Date of Report
- Midvale, Utah (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for Utah Medical Products, Inc.?
The primary purpose of this 8-K filing is to report on the Results of Operations and Financial Condition of Utah Medical Products, Inc., and to include Financial Statements and Exhibits.
When was this 8-K filing submitted?
This 8-K filing was submitted on October 23, 2025.
Where are the principal executive offices of Utah Medical Products, Inc. located?
The principal executive offices of Utah Medical Products, Inc. are located at 7043 South 300 West, Midvale, Utah 84047.
What is the IRS Employer Identification Number (EIN) for Utah Medical Products, Inc.?
The IRS Employer Identification Number (EIN) for Utah Medical Products, Inc. is 87-0342734.
Under which section of the Securities Exchange Act of 1934 is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 555 words · 2 min read · ~2 pages · Grade level 11.8 · Accepted 2025-10-23 15:07:05
Filing Documents
- utmd-20251023_8k.htm (8-K) — 25KB
- utmd_ex99z1.htm (EX-99.1) — 118KB
- 0001096906-25-001708.txt ( ) — 282KB
- utmd-20251023_def.xml (EX-101.DEF) — 2KB
- utmd-20251023_lab.xml (EX-101.LAB) — 20KB
- utmd-20251023_pre.xml (EX-101.PRE) — 13KB
- utmd-20251023.xsd (EX-101.SCH) — 2KB
- utmd-20251023_8k_htm.xml (XML) — 2KB
02—RESULTS OF OPERATIONS AND FINANCIAL CONDITION
ITEM 2.02—RESULTS OF OPERATIONS AND FINANCIAL CONDITION Attached hereto as Exhibit 99.1 and incorporated by reference herein is financial information for Utah Medical Products, Inc. for the three and nine months ended September 30, 2025 and forward-looking statements relating to 2025 and beyond as presented in a press release dated October 23, 2025. The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 2.02 and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.
01—FINANCIAL STATEMENTS AND EXHIBITS
ITEM 9.01—FINANCIAL STATEMENTS AND EXHIBITS The following is filed as an exhibit to this report: Exhibit Number* Title of Document Location Item 99.1 Financial information for Utah Medical Prod ucts, Inc. for the three and nine months ended September 30, 2025 and forward-loo king statements relating to 2025 and beyond as present ed in a press release dated October 23, 2025 . This filing _______________________________________ * All exhibits are numbered with the number preceding the decimal indicating the applicable SEC reference number in Item 601 and the number following the decimal indicating the sequence of the particular document.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. UTAH MEDICAL PRODUCTS, INC. Dated: October 23, 2025 By: /s/ Kevin L. Cornwell Kevin L. Cornwell, Chief Executive Officer